Dr. Bhosale Systemic
Transcript of Dr. Bhosale Systemic
-
7/31/2019 Dr. Bhosale Systemic
1/87
-
7/31/2019 Dr. Bhosale Systemic
2/87
Common systemic diseases
affecting the eye
Infectious
Toxoplasmosis
Toxocariasis
TBSyphilis
Leprosy
HIVCMV
Non-infectiousEndocrine diabetes,thyroid
Connective tissue
diseaseRA/SLE/Wegeners/PAN/Systemic sclerosis
Vasculities (GCA)
Sarcoidosis
Behcets DiseaseVogt Koyanagi Haradasyndrome
Phakomatoses
-
7/31/2019 Dr. Bhosale Systemic
3/87
DIABETIC RETINOPATHY
1. Adverse risk factors
2. Pathogenesis
5. Clinically significant macular oedema
6. Preproliferative diabetic retinopathy
3. Background diabetic retinopathy
4. Diabetic maculopathies Focal Diffuse Ischaemic
7. Proliferative diabetic retinopathy
-
7/31/2019 Dr. Bhosale Systemic
4/87
Location of lesions in backgrounddiabetic retinopathy
-
7/31/2019 Dr. Bhosale Systemic
5/87
Signs of background diabetic retinopathy
Microaneurysmsusuallytemporal to foveaIntraretinal dot andblot haemorrhages
Hard exudatesfrequently
arranged in clumps orrings
Retinal oedemaseen asthickening on biomicroscopy
-
7/31/2019 Dr. Bhosale Systemic
6/87
Preproliferative diabetic retinopathy
Treatment - not required but watch for proliferative disease
Cotton-wool spots
Venous irregularities
Dark blot haemorrhages
Intraretinal microvascularabnormalities (IRMA)
Signs
-
7/31/2019 Dr. Bhosale Systemic
7/87
Proliferative diabetic retinopathy
Flat or elevated
Severity determined by comparing with area of disc
Neovascularization
Neovascularization of disc = NVD
Affects 5-10% of diabetics IDD at increased risk (60% after 30 years)
Neovascularization elsewhere = NVE
-
7/31/2019 Dr. Bhosale Systemic
8/87
Spot size (200-500 m) dependson contact lens magnification
Gentle intensity burn (0.10-0.05 sec)
Follow-up 4 to 8 weeks
Area covered by complete PRP Initial treatment is 2000-3000 burns
Laser panretinal photocoagulation
-
7/31/2019 Dr. Bhosale Systemic
9/87
Retinal Vein Occlusion
Second most common cause of vascular-related visual loss.
Risk factors: hypertension, age, blood dyscrasias (OCP,HRT) and
vasculitis (Behcets,sarcoidosis,AIDS,SLE)
-
7/31/2019 Dr. Bhosale Systemic
10/87
Retinal Artery Occlusion
Risk factors: Carotid artery atherosclerosis (CRAO), carotid emboli
(BRAO), vasculitis (GCA,SLE,PAN), coagulopathy.
-
7/31/2019 Dr. Bhosale Systemic
11/87
1. Soft tissue involvement Periorbital and lid swelling
Conjunctival hyperaemia
Chemosis
Superior limbic keratoconjunctivitis
2. Eyelid retraction
3. Proptosis
4. Optic neuropathy
5. Restrictive myopathy
THYROID EYE DISEASE
-
7/31/2019 Dr. Bhosale Systemic
12/87
Soft tissue involvementPeriorbital and lid swelling
Chemosis
Conjunctival hyperaemia
Superior limbickeratoconjunctivitis
-
7/31/2019 Dr. Bhosale Systemic
13/87
Signs of eyelid retractionOccurs in about 50%
Bilateral lid retraction
No associated proptosis
Bilateral lid retraction
Bilateral proptosis
Lid lag in downgaze Unilateral lid retraction
Unilateral proptosis
i
-
7/31/2019 Dr. Bhosale Systemic
14/87
Proptosis
Treatment options Systemic steroids
Radiotherapy Surgical decompression
Occurs in about 50% Uninfluenced by treatment of hyperthyroidism
Axial and permanent in about 70% May be associated with choroidal folds
-
7/31/2019 Dr. Bhosale Systemic
15/87
Optic neuropathy Occurs in about 5% Early defective colour vision
Usually normal disc appearance
Caused by optic nervecompression atorbital apex by enlarged recti
Often occurs in absence of significantproptosis
R i i h
-
7/31/2019 Dr. Bhosale Systemic
16/87
Occurs in about 40% Due to fibrotic contracture
Restrictive myopathy
Elevation defect - most common Abduction defect - less common
Depression defect - uncommon Adduction defect - rare
-
7/31/2019 Dr. Bhosale Systemic
17/87
SARCOIDOSIS
Idiopathic multisystem disorder
Characterised by non-caseating
granulomata
More common in women 20-50 yrs
More common in blacks and Asians
? Related to mycobacteria
-
7/31/2019 Dr. Bhosale Systemic
18/87
SARCOIDOSIS
Systemic InvolvementLung lesions 95%
Thoracic lymph nodes
50%
Skin lesions 30%
Eyes 30%
-
7/31/2019 Dr. Bhosale Systemic
19/87
SARCOIDOSIS
Ocular InvolvementAnterior segmentlesions (30%)
Conjunctival granuloma
Lacrimal gland
involvement/dry eye Acute or chronic uveitis
KPs described asmutton fat because they
are large and greasy
-
7/31/2019 Dr. Bhosale Systemic
20/87
SARCOIDOSIS
Ocular InvolvementPosterior segmentlesions (20%) Patchy venous sheathing
Cellular infiltrate aroundvessels
Chorioretinalgranulonmas
Vasculitis includingocclusive causing:-
Neovascularisation
Infiltrate in vitreous(vitritis) including cellclumps (snowballs)
-
7/31/2019 Dr. Bhosale Systemic
21/87
SARCOIDOSIS
Ocular InvolvementSheathing of the
retinal veins
Fluoresceinangiography showing
leakage and staining
at sites of sheathing
-
7/31/2019 Dr. Bhosale Systemic
22/87
SARCOIDOSIS
Granuloma in Fundus
Retinal and pre-
retinal
Choroidal
-
7/31/2019 Dr. Bhosale Systemic
23/87
SARCOIDOSIS
Granuloma in FundusOptic nerve head
granuloma
Normal optic nervehead
-
7/31/2019 Dr. Bhosale Systemic
24/87
SARCOIDOSIS
Systemic SignsLupus pernio affecting
the nose a chronic
progressive
cutaneous sarcoidthat most commonly
affects face and ears
-
7/31/2019 Dr. Bhosale Systemic
25/87
SARCOIDOSIS
Systemic signsFacial palsy
Salivary gland
enlargement
-
7/31/2019 Dr. Bhosale Systemic
26/87
SARCOIDOSIS
Systemic signsHilar adenopathy on
chest x-ray
Lung infiltrate
Erythema nodosum
Arthritis
-
7/31/2019 Dr. Bhosale Systemic
27/87
SARCOIDOSIS
Investigations (1)CXR to detect
pulmonary signs
Bilateral hilar lymph-
adenopathy
Pulmonary mottling
-
7/31/2019 Dr. Bhosale Systemic
28/87
SARCOIDOSIS
Investigations (2)
Serum angiotensin-converting enzyme
(ACE) elevated in active sarcoidosis
Mantoux test caution in patients who
have had BCG vaccination. Test may be
negative
Lung function tests
-
7/31/2019 Dr. Bhosale Systemic
29/87
SARCOIDOSIS
Investigations (3)Gallium scan showing
increased uptake in
the lacrimal and
parotid glands andpulmonary regions in
a patient with active
sarcoidosis
-
7/31/2019 Dr. Bhosale Systemic
30/87
SARCOIDOSIS
Treatment
Systemic steroids may be necessary in
patients with posterior segment disease
where vision is threatened, especially if
optic nerve is involved
-
7/31/2019 Dr. Bhosale Systemic
31/87
PHACOMATOSES
1. Neurofibromatosis
2. Tuberous sclerosis (Bourneville disease)
3. von-Hippel-Lindau syndrome
4. Sturge-Weber syndrome
Type I (NF-1) - von Recklinghausen disease
Type II (NF-2) - bilateral acoustic neuromas
Neurofibromatosis type 1 (NF 1)
-
7/31/2019 Dr. Bhosale Systemic
32/87
Neurofibromatosis type-1 - (NF-1)
Appear during first year of life
Caf-au-lait spots
Most common phacomatosis
Increase in size and number throughoutchildhood
Affects 1:4000 individuals
Presents in childhood Gene localized to chromosome 17q11
Fibroma molluscum in NF 1
-
7/31/2019 Dr. Bhosale Systemic
33/87
Fibroma molluscum in NF-1
Appear at puberty
Pedunculated, flabby nodulesconsisting of
neurofibromas or schwannomas
Increase in numberthroughout life
Frequently widely distributed
-
7/31/2019 Dr. Bhosale Systemic
34/87
Plexiform neurofibroma in NF-1
May be associated withovergrowth of overlying skin
Appear during childhood Large and ill-defined
Skeletal defects in NF 1
-
7/31/2019 Dr. Bhosale Systemic
35/87
Skeletal defects in NF-1
Mild head enlargement - uncommon Other - scoliosis, short stature, thinning of
long bones
Facial hemiatrophy
Orbital lesions in NF 1
-
7/31/2019 Dr. Bhosale Systemic
36/87
Orbital lesions in NF-1
Spheno-orbital encephaloceleOptic nerve glioma in about 15%
Sagittal MRI scan of optic nerve
glioma invading hypothalamus
Glioma may be unilateral or
bilateral
Axial CT scan of congenital absence ofleft greater wing of sphenoid bone
Causes pulsating proptosis without bruit
-
7/31/2019 Dr. Bhosale Systemic
37/87
Eyelid neurofibromas in NF-1
Nodular Plexiform
May cause mechanical ptosis May be associated with glaucoma
Intraocular lesions in NF-1
-
7/31/2019 Dr. Bhosale Systemic
38/87
Intraocular lesions in NF-1Lisch nodules
Very common - eventually presentin 95% of cases
Congenital ectropion uveae
Uncommon - may be associatedwith glaucoma
Retinal astrocytomas
Rare - identical to those seen in
tuberous sclerosis
Choroidal naevi
Common - may be multifocal
and bilateral
-
7/31/2019 Dr. Bhosale Systemic
39/87
Ocular features of NF-2
Common - combined hamartomas of RPand retina
Very common -presenile cataract
Tuberous sclerosis (Bourneville disease)
-
7/31/2019 Dr. Bhosale Systemic
40/87
Tuberous sclerosis (Bourneville disease)
Diffuse thickening overlumbar region
Present in 40%
Shagreen patches
Autosomal dominant Triad - mental handicap, epilepsy, adenoma sebaceum
Adenoma sebaceum
Around nose andcheeks
Appear after age 1
and slowly enlarge
Ash leaf spots
Hypopigmented skin patches
In infants best detected usingultraviolet light (Woods lamp)
Systemic hamartomas in tuberous sclerosis
-
7/31/2019 Dr. Bhosale Systemic
41/87
Systemic hamartomas in tuberous sclerosisAstrocytic cerebral hamartomas
Slow-growing periventricular tumours
May cause hydrocephalus, epilepsy andmental retardation
Usually asymptomatic andinnocuous
Kidneys (angiomyolipoma), heart
(rhabdomyoma)
Visceral and subungual hamartomas
R ti l t t i t b l iti
-
7/31/2019 Dr. Bhosale Systemic
42/87
Retinal astrocytomas in tuberous scleritis
Dense white tumour Mulberry-like tumour
Early
Innocuous tumour present in 50% of patients May be multiple and bilateral
Semitranslucent nodule White plaque
Advanced
Systemic features of v-H-L syndrome
-
7/31/2019 Dr. Bhosale Systemic
43/87
Systemic features of v H L syndromeAutosomal dominant
Tumours - renalcarcinoma and
phaeochromocytoma
Cysts - kidneys, liver,pancreas, epididymis,ovary and lungs
Polycythaemia
CNS Haemangioblastoma
MRI of spinal cord tumour
Angiogram of cerebellartumour
Visceral tumours
Retinal capillary haemangioma
-
7/31/2019 Dr. Bhosale Systemic
44/87
Retinal capillary haemangiomain v-H-L syndrome
Round orange-red mass
Early
Vision-threatening tumour present in 50% of patients May be multiple and bilateral
Tiny lesion betweenarteriole and venuole
Small red nodule
Associated dilatation and
tortuosity of feeder vessels
Advanced
Systemic features of Sturge Weber syndrome
-
7/31/2019 Dr. Bhosale Systemic
45/87
Systemic features of Sturge-Weber syndrome
Congenital, does not blanchewith pressure
Associated with ipsilateralglaucoma in 30% of cases
Naevus flammeus
CT scan showing leftparietal haemangioma
Complications - mental handicap,epilepsy and hemiparesis
Meningeal haemangioma
Ocular features of Sturge-Weber syndrome
-
7/31/2019 Dr. Bhosale Systemic
46/87
Ocular features of Sturge Weber syndrome
Normal eye
Buphthalmos in 60% May be associated with
episcleral haemangioma
Affected eye
Diffuse choroidal haemangioma
Glaucoma
Peripheral corneal involvement in
-
7/31/2019 Dr. Bhosale Systemic
47/87
Peripheral corneal involvement inrheumatoid arthritis
Chronic and asymptomatic
Circumferential thinning with intactepithelium (contact lens cornea)
Acute and painful
Circumferential ulceration andinfiltration
Treatment - systemic steroids and/or cytotoxic drugs
Without inflammation With inflammation
Peripheral corneal involvement in
-
7/31/2019 Dr. Bhosale Systemic
48/87
Peripheral corneal involvement inegener granulomatosis and polyarteritis nodo
Circumferential and centralulceration similar to Mooren ulcer
Unlike Mooren ulcer sclera may alsobecome involved
Treatment - systemic steroids and cyclophosphamide
-
7/31/2019 Dr. Bhosale Systemic
49/87
GIANT CELL ARTERITIS
-
7/31/2019 Dr. Bhosale Systemic
50/87
GIANT CELL ARTERITIS
PresentationHeadache
Scalp tenderness
Thickened temporal
arteriesJaw claudication
Acute visual loss
Weight loss, anorexia,
fever, night sweats,malaise & depression
GIANT CELL ARTERITIS
-
7/31/2019 Dr. Bhosale Systemic
51/87
GIANT CELL ARTERITIS
Ocular ComplicationsTransient monocularvisual loss (amaurosisfugax)
Visual loss due to Central retinal artery
occlusion (CRAO) or
Anterior ischaemicoptic neuropathy
(AION)Visual field defects
GIANT CELL ARTERITIS
-
7/31/2019 Dr. Bhosale Systemic
52/87
GIANT CELL ARTERITIS
ManagementESR if suspected
Start high dose steroids immediately to
prevent stroke or second eye involvement
Temporal artery biopsy within a week of
starting steroids
GIANT CELL ARTERITIS
-
7/31/2019 Dr. Bhosale Systemic
53/87
GIANT CELL ARTERITIS
Temporal Artery BiopsyArteries have skiplesions
ultrasound/Doppler mayhelp identify involved
areasIf positive, confirmsdiagnosis helpful inmanagement of futuredisease
If negative, doesntexclude diagnosis, butneed to think about analternative diagnosis
GIANT CELL ARTERITIS
-
7/31/2019 Dr. Bhosale Systemic
54/87
GIANT CELL ARTERITIS
HistopathologyGranulomatous cell
infiltration
Giant cells
Disruption of internalelastic lamina
Proliferation of intima
Occlusion of lumen
GIANT CELL ARTERITIS
-
7/31/2019 Dr. Bhosale Systemic
55/87
GIANT CELL ARTERITIS
Treatment
Intravenous and oral steroids prolonged
course of steroids often necessary
-
7/31/2019 Dr. Bhosale Systemic
56/87
Ocular manifestations of
HIV infection
I t d ti
-
7/31/2019 Dr. Bhosale Systemic
57/87
Introduction
AIDS is an infectious disease caused by the gradual
decrease in CD4+ T lymphocytes causing
subsequent opportunistic infections and neoplasia. It
is a blood borne and sexually transmitted infection
caused by the HIV (Human Immunodeficiency Virus)Approximately 36 million persons around the world
are infected. Up to 70% of patients infected with HIV
will develop some form of ocular involvement, ie:
direct infection by HIV,opportunistic infections andneoplasia.
HIV infection progresses though different phases
-
7/31/2019 Dr. Bhosale Systemic
58/87
Ophthalmic Manifestations of HIV Infection
AROUND THE EYE
Molluscum Contagiosum
Herpes Zoster
Ophthalmicus
Kaposis Sarcoma Conjunctival Squamous
Cell Carcinoma
Trichomegaly
FRONT OF THE EYE
Dry Eye
Anterior Uveitis
BACK OF THE EYE
Retinal Microvasculopathy
CMV Retinitis
Acute Retinal Necrosis
Progressive Outer RetinalNecrosis
Toxoplasmosis
Retinochoroiditis
Syphilis Retinitis
Candida albicansendophthalmitis
NEURO-OPHTHALMIC
M ll C t i
-
7/31/2019 Dr. Bhosale Systemic
59/87
Molluscum Contagiosum
Molluscum contagiosum is a
viral infection of the skin.
Affects up to 20% of
symptomatic HIV infected
patients.
Clinically appears like painless,
small, umbilicated nodules,
which produce a waxy
discharge when pressured.
Treatment consists on excision
of the lesion, curettage or
cryotherapy
Herpes Zoster Ophthalmicus
-
7/31/2019 Dr. Bhosale Systemic
60/87
Herpes Zoster Ophthalmicus
Due to the reactivation of a latent infection by Varicella
Zoster Virus in the dorsal root of trigeminal nerve
ganglion.
It manifests with a maculo-papulo-vesicular rash whichoften is preceded by pain. Usually involves the upper lid
and does not cross the midline
Treatment consists on oral Aciclovir 800mg 5 times
/day. In immunocompromised patients Aciclovir is givenintravenously for two weeks. Ocular manifestations
such as anterior uveitis, are treated with topical steroids
and mydriatics.
-
7/31/2019 Dr. Bhosale Systemic
61/87
Kaposis Sarcoma
-
7/31/2019 Dr. Bhosale Systemic
62/87
Kaposi s Sarcoma
Kaposis sarcoma is a vascular neoplasm which is almost
exclusively seen in patients with AIDS.
KS is the commonest anterior segment lesion seen in AIDS;
appears as a violaceous non-tender nodule on the eyelid or
conjunctiva.
Typically KS involves only the skin but when there is a
reduced CD4 count it can progress rapidly to other sites
such as the gastrointestinal tract and CNS
Treatment of ocular adnexal KS may be necessary for
cosmesis and to relieve functional difficulties. The mainstay
of treatment is radiotherapy. Other options include
cryotherapy or chemotherapy.
-
7/31/2019 Dr. Bhosale Systemic
63/87
-
7/31/2019 Dr. Bhosale Systemic
64/87
Conjunctival Squamous Cell Carcinoma
Squamous cell carcinoma (SCC) is the third mostcommon neoplasm associated to HIV infection. This may
be due to an interaction between HIV, sunlight and
Human Papilloma Virus infection.
SCC appears as a pink, gelatinous growth, usually in theinterpalpebral area. Often an engorgedblood vesselfeeding the tumour is seen. It may extend onto the
cornea, but deep invasion and metastasis are rare.
The treatment of choice is local excision and cryotherapybut the presence of orbital invasion is an indication of
exenteration
-
7/31/2019 Dr. Bhosale Systemic
65/87
-
7/31/2019 Dr. Bhosale Systemic
66/87
Trichomegaly
Trichomegaly orhypertrichosis is an
exaggerated growth of
the eye lashes found in
the later stages of thedisease
The cause is not known
When symptomatic or for
cosmetic reasons theeyelashes can be
trimmed or plucked
-
7/31/2019 Dr. Bhosale Systemic
67/87
Dry EyeSicca syndrome is
frequent amongpatients with HIV
infection
Patients complain of
burning uncomfortablered eyes.
There are several
causes of dry eye in
HIV infection from
blepharitis to
destruction of the
lacrimal glands.
Treatment is with tear
supplements
Anterior Uveitis
-
7/31/2019 Dr. Bhosale Systemic
68/87
Anterior Uveitis
HIV related anterioruveitis can
be: Direct manifestation of the
human immunodeficiency
virus infection
autoimmnune in origin drug induced ie: rifabutin,
secondary to direct toxic
effect upon the non-
pigmented epithelium of the
ciliary body
Any of the different infections
associated with AIDS, ie:
Herpes Zoster Virus, Herpes
Simplex Virus,
Rifabutin induced anterior uveitis
-
7/31/2019 Dr. Bhosale Systemic
69/87
Rifabutin induced anterior uveitis
-
7/31/2019 Dr. Bhosale Systemic
70/87
Retinal microvasculitis
Retinal microvasculopathy occurs in more than half of thepatients with HIV
It is seen as transient cotton wool spots (CWS), intra-retinal
haemorrhages and microaneurysm, which occurs in 50-70% of
patients. It is usually asymptomatic.It has an unclear pathogenesis, but it is thought to be HIV
infection of retinal vascular cells.
In an otherwise healthy individual the presence of CWS, should
be differentiated from other forms of retinopathy, such asdiabetic or hypertensive retinopathy. Serological test for HIV will
confirm the diagnosis
Treatment is based in delaying the progression of the disease
associated with HIV
-
7/31/2019 Dr. Bhosale Systemic
71/87
Cotton Wool Spots
CMV Retinitis
-
7/31/2019 Dr. Bhosale Systemic
72/87
CMV Retinitis
Introduction
CMV Retinitis is the commonest intraocular ocular opportunistic infectionseen in patients with AIDS
Antibodies are found in almost 95% of adults, causing a trivial illness in
immunocompetent adults, however severe immunosuppression causes
viral reactivation and tissue invasive disease
Pathogenesis
Reactivation from extraocular sites leads to seeding in other sites such
as the retina
Epidemiology
The number of newly diagnosed cases of CMVR has decreased sincethe introduction of the HAART
Highly Active Antiretroviral Therapy
CMV Retinitis
-
7/31/2019 Dr. Bhosale Systemic
73/87
CMV Retinitis
Clinical manifestations
Patients may complain of minor visual symptoms such as floaters,flashing lights or mild blurred vision, or be totally asymptomatic.
It presents with a wide range ofclinical appearances. From cotton wool
spots which may look like HIV Retinopathy to confluent areas of full
thickness retinal necrosis and vasculitis. CMVR can progress in a
brushfire pattern from the active edge of an active lesion. The retinalvessels in an affected area show attenuation, becoming ghost vessels
eventually.
Treatment
The treatment of CMVR in patients with AIDS requires the use of specific
antiviral agents, ganciclovir, foscarnet or cidovir in conjunction withHAART.
These treatments can be administered orally, intravenously or
intravitreally. Systemic treatment has the advantage of treating infection
elsewhere in the body as well as the other eye but has the
disadvantages of systemic side effects.
CMV Retinitis
-
7/31/2019 Dr. Bhosale Systemic
74/87
CMV Retinitis
Acute Retinal Necrosis
-
7/31/2019 Dr. Bhosale Systemic
75/87
Acute Retinal Necrosis
ARN is a confluent peripheral whitening of the retina withmarked vitritis and blood vessel closure. Optic neuritis
and retinal detachment are frequent complications.
ARN is usually due to Varicella-Zoster infection, but it can
also be caused by Herpes Simplex virus or
Cytomegalovirus.
Initially described in the immunocompetent, it has also
been described in the immunosuppressed.
The diagnosis is mainly clinical and is confirmed by PCR
assays on vitreous samples.
Patients are treated with high doses of intravenous
aciclovir or famciclovir, combined with laser treatment to
prevent retinal detachment.
Acute Retinal Necrosis
-
7/31/2019 Dr. Bhosale Systemic
76/87
Acute Retinal Necrosis
rogress ve u er e naNecrosis
-
7/31/2019 Dr. Bhosale Systemic
77/87
Necrosis
(Varicella-Zoster Retinitis)
PORN is a devastating viral retinitis caused by Varicella-Zostervirus, without vitritis or retinal vasculitis.
The retinitis can be located anywhere but it is common for the
lesions to coalesce and spread posteriorly in a rapid fashion.
The main symptom is rapid loss of vision.The retina showstypically a white lesion with no haemorrhages or exudates.
Treatment is often unsatisfactory and usually requires
combination of Ganciclovir and Aciclovir. The prognosis is very
poor and retinal detachment is common. Resolution may leavea white plaque with the appearance of cracked mud.
-
7/31/2019 Dr. Bhosale Systemic
78/87
Toxoplasma Retinochoroiditis
-
7/31/2019 Dr. Bhosale Systemic
79/87
Toxoplasma Retinochoroiditis
Toxoplasmosis retinochoroiditis is an uncommoninfection of the eye in AIDS. Ocular toxoplasmosis in HIV
positive patients is different in appearance from
immunocompetent patients. Unlike in immunocompetent
patients, HIV infected patients often have bilateral andmultifocal disease associated with anterior uveitis and
vitritis but unlike immunocompetent patients, in HIV
infected patients often have with no pigmented scars
adjacent to the areas of retinal necrosis. Toxoplasmosis
in immunocompromised patients is not self-limiting as it
is in imunocompetent patients.
Toxoplasma Retinochoroiditis
-
7/31/2019 Dr. Bhosale Systemic
80/87
Toxoplasma Retinochoroiditis
When testing patients for antibodies to toxoplasmosisboth IgG and IgM levels may be raised, but in
immunocompromised patients these tests may be
negative.
Treatment in immunocompromised patients consists inthe association of sulphadiazine or clindamycin,
pyrimethamine and folinic acid (triple therapy).
Long term maintenance treatment may be needed in
order to prevent relapses.Often associated with toxoplasma lesions in the Central
Nervous System.
-
7/31/2019 Dr. Bhosale Systemic
81/87
MRI T1 showing an uniformly
enhancing lesion in the
midbrain
One week later, the lesion
showing ring enhancement
-
7/31/2019 Dr. Bhosale Systemic
82/87
Immunocompetent Immunocompromised
Syphilis Retinitis
-
7/31/2019 Dr. Bhosale Systemic
83/87
Syphilis Retinitis
There is a strong association between syphilis andHIV infection.
It can manifest as a retinitis with dense vitritis,
retinal vasculitis, serous retinal detachment or
neuroretinitis, as well as other types of ocularinvolvement such as, conjunctivitis, anterior uveitis,
cranial nerve palsies and optic neuritis.
Treatment consists in high dose of intravenous
Penicillin for 2 weeks.
-
7/31/2019 Dr. Bhosale Systemic
84/87
Candida albicans
d hth l iti
-
7/31/2019 Dr. Bhosale Systemic
85/87
endophthalmitis
Infection with candida albicans is rare. Candida albicansis the commonest cause of fungal endophthalmitis
Affected patients usually have a history of drug abuse
or indwelling central lines
In the initial stages, floaters are the main symptom. Asthe condition progresses, whitish puff-balls and
vitreous strands develop. Later, similar infiltrates appear
in the choroid and retina
The treatment depends on the severity of the ocularinvolvement and systemic disease. The original foci
should be removed. The drugs of choice are
Amphotericine B and Fluconazol
Candida albicans
d hth l iti
-
7/31/2019 Dr. Bhosale Systemic
86/87
endophthalmitis
Glossary
-
7/31/2019 Dr. Bhosale Systemic
87/87
Glossary
CD4: Director of the immune response. When activated it
releases cytokines which in turn will activate the immunesystem
Cotton Wool Spots: Light-coloured deposits in the retinasecondary to infarcts of the nerve fibre layer
HAART: Highly Active Antiretroviral TherapyImmunoblogulin: Protein in charge of fighting foreignsubstances in our body. IgG is the commonest type of
immunoglobulin and IgM is the earliest class
of immunoglobulin.PCR: Polymerase Chain Reaction is a technique used to make
numerous copies of an specific portion of DNA
VDRL: Venereal Disease Research Laboratory The test